–
Статьи в журналах
-
- 2011 Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate 29. [Epub ahead of print
- Sonpavde G., Matveev V., Burke JM, Caton JR, Fleming MT, Hutson TE, Galsky MD, Berry WR, Karlov P., Holmlund JT, ood BA, Brookes M., Leopold L.
- в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom)